2022
DOI: 10.1016/j.addr.2022.114502
|View full text |Cite
|
Sign up to set email alerts
|

Strategies and progresses for enhancing targeted antibiotic delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 43 publications
(17 citation statements)
references
References 334 publications
0
17
0
Order By: Relevance
“…Therefore, local release of antibiotics has become a focus of attention for researchers. Topical antibiotic therapy is the delivery of drugs to the site of infection, and it reduces the minimum dose of drug required 181 . Local release of antibiotics increases the therapeutic concentration of the drug, thereby reducing systemic absorption of the drug and reducing the potential risk of adverse effects and bacterial resistance.…”
Section: Electrospinning Wound Dressing With Functional Substancementioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, local release of antibiotics has become a focus of attention for researchers. Topical antibiotic therapy is the delivery of drugs to the site of infection, and it reduces the minimum dose of drug required 181 . Local release of antibiotics increases the therapeutic concentration of the drug, thereby reducing systemic absorption of the drug and reducing the potential risk of adverse effects and bacterial resistance.…”
Section: Electrospinning Wound Dressing With Functional Substancementioning
confidence: 99%
“…Topical antibiotic therapy is the delivery of drugs to the site of infection, and it reduces the minimum dose of drug required. 181 Local release of antibiotics increases the therapeutic concentration of the drug, thereby reducing systemic absorption of the drug and reducing the potential risk of adverse effects and bacterial resistance. Amiri et al 59 utilized nanofibers composed of CS and PEO combined with teicoplanin for localized antibiotic delivery and wound healing purposes.…”
Section: Antibacterial Agentmentioning
confidence: 99%
“…Nanocarriers can selectively transport antibiotics to the site of infection due to their targeting properties, thus improving drug distribution, increasing the effectiveness of antibiotics, reducing drug side effects and overcoming bacterial resistance ( Nazli et al, 2022 ). Many nanomaterials have been used in antimicrobial therapy, such as inorganic metal nanomaterials (gold, silver, copper, zinc, titanium), metal oxide nanoparticles (copper oxide, zinc oxide, titanium oxide, iron oxide), carbon-based nanomaterials (graphene and its derivatives, graphene quantum dots, carbon quantum dots), and organic nanostructures (chitosan, dendrimers, liposomes, micelles, vesicles), etc.…”
Section: Introductionmentioning
confidence: 99%
“…( Modi et al, 2022 ). The antibacterial mechanisms of nanomaterials involve 1) the use of size, surface properties and other unique physicochemical properties to damage important intracellular components and interfere with the normal physiological metabolic processes of bacteria, ultimately leading to bacterial death ( Cheng et al, 2022 ); 2) the use of the enzyme-like activity of nanomaterials, regulating the level of reactive oxygen species (ROS) to exert a strong bactericidal effect by disrupting bacterial biofilms ( Godoy-Gallardo et al, 2021 ); 3) smart response platforms based on nanomaterials, such as pH, enzymes and temperature to enhance antimicrobial activity ( Jiang et al, 2020 ); 4) the use of external stimulus-response properties of nanomaterials, such as light and microwaves, or synergistic antimicrobial drugs to achieve an antimicrobial activity in a single or combined treatment ( Díez-Pascual, 2020 ; Nazli et al, 2022 ). Zeolite imidazole ester skeleton—8 (ZIF—8) is a porous crystalline material formed by the coordination self-assembly of zinc ion and 2-methylimidazole.…”
Section: Introductionmentioning
confidence: 99%
“…[7] A promising strategy is using intracellular delivery to enhance the antibacterial efficacy of currently available antibiotics. [8] For example, conjugation of anti-S. aureus antibody to rifalogue significantly boosted the antibacterial capability of the antibiotic to kill intracellular S. aureus. [9] However, antibody variability may weaken the antibacterial efficacy of these antibody-antibiotic conjugates and thus limit their further applications.…”
Section: Introductionmentioning
confidence: 99%